| Literature DB >> 33567452 |
Prasad P Devarshi1, LeeCole L Legette1, Ryan W Grant1, Susan Hazels Mitmesser1.
Abstract
BACKGROUND: Women of childbearing age (WCBA) and women of menopausal age (WMENO) have distinct nutritional needs. Understanding nutrient intake and status in these life stages is critical for tailoring dietary recommendations.Entities:
Keywords: NHANES; dietary assessment; dietary supplement; nutrient biomarker; nutrient gaps; nutrition during menopause; nutrition during pregnancy; prenatal nutrition; shortfall nutrients; underconsumed nutrients
Mesh:
Substances:
Year: 2021 PMID: 33567452 PMCID: PMC8023996 DOI: 10.1093/ajcn/nqaa392
Source DB: PubMed Journal: Am J Clin Nutr ISSN: 0002-9165 Impact factor: 7.045
Study population characteristics[1]
| WCBA (15–44 y) | WMENO (40–65 y) | |||||
|---|---|---|---|---|---|---|
| Supplement/antacid use | Supplement/antacid use | |||||
| Total | Yes | No | Total | Yes | No | |
|
| 4134 | 1790 | 2344 | 3438 | 2172 | 1266 |
| Age, mean ± SE (y) | 29.2 ± 0.3 | 30.8 ± 0.4 | 27.8 ± 0.3 | 52.4 ± 0.2 | 53.2 ± 0.2 | 50.8 ± 0.3 |
| Age group, % | ||||||
| 15–30 y | 54.7 | 47.3 | 61.3 | — | — | — |
| 31–44 y | 45.3 | 52.7 | 38.7 | — | — | — |
| 40–50 y | — | — | — | 41.6 | 37.0 | 51.8 |
| 51–65 y | — | — | — | 58.4 | 63.0 | 48.2 |
| Race/ethnicity, % | ||||||
| Mexican American | 13.1 | 9.1 | 16.8 | 7.4 | 5.8 | 11.0 |
| Other Hispanic | 7.8 | 7.1 | 8.3 | 5.6 | 4.8 | 7.3 |
| Non-Hispanic white | 54.9 | 61.8 | 48.8 | 66.8 | 70.9 | 57.8 |
| Non-Hispanic black | 14.4 | 11.5 | 17.1 | 12.2 | 10.2 | 16.7 |
| Other race (including multiracial) | 9.7 | 10.6 | 9.0 | 8.0 | 8.4 | 7.2 |
| Household income, % | ||||||
| <1.35 of PIR | 33.7 | 26.3 | 40.5 | 21.4 | 17.2 | 30.5 |
| 1.35–1.85 of PIR | 11.3 | 10.7 | 11.8 | 8.0 | 7.3 | 9.4 |
| >1.85 of PIR | 55.0 | 63.0 | 47.7 | 70.7 | 75.4 | 60.1 |
| Household reference education, % | ||||||
| ≤ high school | 37.3 | 29.5 | 44.3 | 34.8 | 30.5 | 44.1 |
| > high school | 62.7 | 70.5 | 55.7 | 65.2 | 69.5 | 55.9 |
| BMI, % | ||||||
| Underweight | 2.7 | 2.5 | 2.9 | 1.2 | 1.1 | 1.4 |
| Normal | 38.8 | 42.1 | 35.9 | 27.2 | 29.4 | 22.6 |
| Overweight | 24.3 | 22.7 | 25.6 | 28.3 | 28.1 | 28.8 |
| Obese | 34.3 | 32.8 | 35.6 | 43.3 | 41.4 | 47.3 |
| On a special diet | ||||||
| Yes | 15.2 | 18.7 | 12.0 | 20.2 | 22.6 | 14.9 |
| No | 84.8 | 81.3 | 88.0 | 79.8 | 77.4 | 85.1 |
PIR, poverty income ratio; WCBA, women of childbearing age; WMENO, women of menopausal age.
Number of women reporting using a supplement with the specific nutrient in the previous 30 d, NHANES 2011–2016[1]
| No. (%) of women reporting using a supplement with the specific component in the previous 30 d | ||||
|---|---|---|---|---|
| WCBA | WMENO | |||
| 15–30 y | 31–44 y | 40–50 y | 51–65 y | |
| Nutrient | ( | ( | ( | ( |
| Vitamin A, RAE | 465 (22.3) | 512 (32.1) | 442 (33.6) | 607 (35.1) |
| Retinol | 392 (18.7) | 443 (27.9) | 395 (29.9) | 551 (31.3) |
| Vitamin E as α-tocopherol | 481 (23.1) | 545 (33.5) | 469 (34.5) | 665 (38.5) |
| Vitamin D (D-2 + D-3) | 528 (25.3) | 600 (36.7) | 554 (41.4) | 905 (52.5) |
| Vitamin K | 220 (11.2) | 311 (19.4) | 282 (21.3) | 446 (26.1) |
| Vitamin C | 562 (26.9) | 593 (36.2) | 516 (37.1) | 734 (41.5) |
| Thiamin (vitamin B-1) | 358 (18.0) | 442 (27.0) | 389 (29.5) | 569 (32.7) |
| Riboflavin (vitamin B-2) | 359 (18.0) | 448 (27.2) | 391 (29.1) | 576 (33.3) |
| Niacin | 425 (20.9) | 497 (30.1) | 425 (31.5) | 618 (36.3) |
| Vitamin B-6 | 488 (24.1) | 540 (33.2) | 463 (34.3) | 640 (37.0) |
| Folate, DFE | 485 (23.7) | 535 (33.0) | 462 (35.0) | 623 (35.7) |
| Folic acid | 485 (23.7) | 535 (33.0) | 462 (35.0) | 623 (35.7) |
| Vitamin B-12 | 500 (24.4) | 569 (34.9) | 497 (36.8) | 698 (40.6) |
| Total choline | 148 (7.2) | 148 (8.6) | 123 (8.4) | 112 (7.7) |
| Calcium | 519 (26.8) | 589 (36.5) | 565 (41.4) | 911 (52.5) |
| Iron | 345 (16.3) | 410 (24.2) | 355 (25.2) | 345 (20.2) |
| Magnesium | 292 (15.1) | 385 (23.7) | 360 (27) | 595 (35.8) |
| Phosphorus | 136 (5.9) | 130 (8.6) | 147 (10.6) | 316 (18.8) |
| Potassium | 121 (5.7) | 156 (9.8) | 145 (10.9) | 346 (20.7) |
| Sodium | 134 (7.0) | 118 (7.4) | 133 (10.0) | 213 (11.8) |
| Zinc | 408 (20.5) | 467 (28.4) | 408 (29.3) | 572 (32.9) |
| Copper | 253 (12.5) | 357 (21.9) | 320 (23.7) | 501 (29.6) |
| Selenium | 242 (12.1) | 348 (21.7) | 323 (24.5) | 493 (30.1) |
| Protein | 24 (1.4) | 44 (2.5) | 44 (3.6) | 87 (5.0) |
| Carbohydrate | 274 (13.3) | 272 (16.6) | 247 (18.6) | 315 (19.6) |
| Total fat | 107 (5.1) | 171 (10.1) | 155 (11.2) | 336 (18.4) |
| Dietary fiber | 25 (1.6) | 26 (1.3) | 34 (3.0) | 43 (3.3) |
| Total SFAs | 30 (1.3) | 44 (2.4) | 39 (2.5) | 79 (4.5) |
| Total MUFAs | 12 (0.3) | 24 (1.3) | 20 (0.9) | 34 (1.8) |
| Total PUFAs | 42 (2.1) | 73 (4.2) | 77 (6.0) | 138 (7.8) |
| PFA EPA | 64 (2.5) | 90 (5.7) | 74 (4.9) | 153 (9.5) |
| PFA DHA | 76 (3.2) | 101 (6.2) | 83 (5.2) | 163 (10.3) |
| Lycopene | 27 (1.3) | 54 (3.2) | 63 (4.5) | 168 (10.7) |
| Lutein + zeaxanthin | 73 (3.2) | 99 (6.0) | 98 (8.0) | 284 (17.9) |
DFE, dietary folate equivalents; PFA, polyunsaturated fatty acid; RAE, retinol activity equivalents; WCBA, women of childbearing age; WMENO, women of menopausal age.
Percentage of WCBA aged 15–44 y with usual intake from food only and food and supplements
| WCBA age group 15–30 y ( | 31–44 y ( | |||
|---|---|---|---|---|
| Nutrient | Food only | Food + supplements | Food only | Food + supplements |
| % <EAR | ||||
| Vitamin A, RAE (µg) | 50.1 ± 2.3 | 42.3 ± 2.1 | 44.2 ± 2.2 | 33.6 ± 1.9 |
| Vitamin E as α-tocopherol (mg) | 92.2 ± 1.0 | 76.1 ± 1.6 | 87.9 ± 1.4 | 63.4 ± 1.7 |
| Vitamin D (D-2 + D-3) (µg) | >97 | 80.7 ± 1.5 | >97 | 68.9 ± 1.7 |
| Vitamin C (mg) | 46.9 ± 2.2 | 38.9 ± 1.9 | 45.9 ± 2.2 | 34.4 ± 1.9 |
| Thiamin (vitamin B-1) (mg) | 3.2 ± 0.8 | 2.9 ± 0.7 | <3 | <3 |
| Riboflavin (vitamin B-2) (mg) | 5.3 ± 0.7 | 4.8 ± 0.6 | 2.6 ± 0.4 | <3 |
| Niacin (mg) | <3 | <3 | <3 | <3 |
| Vitamin B-6 (mg) | 7.1 ± 1.1 | 6.1 ± 0.9 | 8.1 ± 0.8 | 6.4 ± 0.7 |
| Folate, DFE (µg) | 19.7 ± 1.5 | 16.7 ± 1.3 | 17.5 ± 1.6 | 13.4 ± 1.3 |
| Vitamin B-12 (µg) | 7.8 ± 1.1 | 6.4 ± 0.9 | 7.1 ± 0.9 | 5.1 ± 0.7 |
| Calcium (mg) | 49.2 ± 1.6 | 44.2 ± 1.6 | 43.7 ± 1.9 | 35.7 ± 1.8 |
| Iron (mg) | 11.5 ± 1.1 | 10.1 ± 1.0 | 9.5 ± 1.1 | 7.6 ± 1.0 |
| Magnesium (mg) | 61.7 ± 1.9 | 58.5 ± 1.9 | 43.7 ± 1.8 | 39.5 ± 1.8 |
| Phosphorus (mg) | <3 | <3 | <3 | <3 |
| Zinc (mg) | 20.1 ± 1.6 | 17.6 ± 1.4 | 14.5 ± 1.3 | 11.8 ± 1.2 |
| Copper (mg) | 16.7 ± 1.3 | 15.7 ± 1.2 | 9.4 ± 0.8 | 8.3 ± 0.7 |
| Selenium (µg) | <3 | <3 | <3 | <3 |
| Protein (g) | 3.3 ± 0.5 | 3.3 ± 0.5 | <3 | <3 |
| Carbohydrate (g) | <3 | <3 | <3 | <3 |
| % >AI | ||||
| Vitamin K (µg) | 57.3 ± 1.9 | 59.1 ± 1.9 | 57.1 ± 2.2 | 60.5 ± 2.1 |
| Total choline (mg) | 4.0 ± 0.7 | 4.2 ± 0.7 | 5.7 ± 0.9 | 6.2 ± 0.8 |
| Potassium (mg) | 33.5 ± 1.9 | 33.7 ± 1.9 | 32.0 ± 1.6 | 32.3 ± 1.6 |
| Sodium (mg) | >97 | >97 | >97 | >97 |
| Dietary fiber (g) | 4.2 ± 0.6 | 4.3 ± 0.6 | 7.8 ± 0.9 | 7.9 ± 0.9 |
| PFA ALA (g) | 77.4 ± 1.8 | NA | 81.9 ± 1.8 | NA |
Values are means ± SEs unless otherwise indicated. AI, Adequate Intake; ALA, α-linolenic acid; DFE, dietary folate equivalents; EAR, Estimated Average Requirement; NA, not available; PFA, polyunsaturated fatty acid; RAE, retinol activity equivalents; WCBA, women of childbearing age.
Percentage of WMENO aged 40–65 y with usual intake from food only and food + supplements
| WMENO age group 40–50 y ( | 51–65 y ( | |||
|---|---|---|---|---|
| Nutrient | Food only | Food + supplements | Food only | Food + supplements |
| % <EAR | ||||
| Vitamin A, RAE (µg) | 43.8 ± 2.7 | 33.0 ± 2.1 | 36.5 ± 2.1 | 27.1 ± 1.6 |
| Vitamin E as α-tocopherol (mg) | 88.1 ± 1.6 | 62.7 ± 2.0 | 86.3 ± 1.8 | 57.3 ± 1.9 |
| Vitamin D (D-2 + D-3) (µg) | >97 | 64.1 ± 1.9 | >97 | 51.4 ± 1.5 |
| Vitamin C (mg) | 43.6 ± 2.5 | 32.5 ± 2.1 | 41.4 ± 1.7 | 28.6 ± 1.3 |
| Thiamin (vitamin B-1) (mg) | <3 | <3 | <3 | <3 |
| Riboflavin (vitamin B-2) (mg) | 3.1 ± 0.5 | 2.6 ± 0.5 | 2.6 ± 0.4 | <3 |
| Niacin (mg) | <3 | <3 | 2.6 ± 0.4 | <3 |
| Vitamin B-6 (mg) | 10.6 ± 1.3 | 8.3 ± 1.0 | 20.8 ± 1.8 | 15.2 ± 1.4 |
| Folate, DFE (µg) | 19.9 ± 2.3 | 15.0 ± 1.7 | 18.9 ± 1.9 | 14.0 ± 1.4 |
| Vitamin B-12 (µg) | 8.8 ± 1.2 | 6.2 ± 0.9 | 7.3 ± 1.2 | 4.9 ± 0.8 |
| Calcium (mg) | 47.6 ± 2.1 | 37.3 ± 2.0 | 73.9 ± 1.5 | 50.9 ± 1.5 |
| Iron (mg) | 11.5 ± 1.5 | 9.2 ± 1.3 | <3 | <3 |
| Magnesium (mg) | 49.8 ± 2.0 | 44.6 ± 2.0 | 48.7 ± 1.8 | 40.7 ± 1.8 |
| Phosphorus (mg) | <3 | <3 | <3 | <3 |
| Zinc (mg) | 16.6 ± 1.6 | 13.5 ± 1.4 | 16.2 ± 1.6 | 12.6 ± 1.3 |
| Copper (mg) | 10.1 ± 1.0 | 8.9 ± 0.9 | 9.3 ± 1.2 | 7.7 ± 1.0 |
| Selenium (µg) | <3 | <3 | <3 | <3 |
| Protein (g) | <3 | <3 | <3 | <3 |
| Carbohydrate (g) | <3 | <3 | <3 | <3 |
| % >AI | ||||
| Vitamin K (µg) | 59.8 ± 2.5 | 63.2 ± 2.3 | 63.0 ± 2.2 | 67.5 ± 2.0 |
| Total choline (mg) | 5.4 ± 0.9 | 5.8 ± 0.9 | 5.8 ± 0.8 | 6.4 ± 0.8 |
| Potassium (mg) | 33.7 ± 1.7 | 34.1 ± 1.7 | 38.4 ± 1.5 | 39.4 ± 1.5 |
| Sodium (mg) | >97 | >97 | >97 | >97 |
| Dietary fiber (g) | 7.1 ± 0.7 | 7.5 ± 0.7 | 9.4 ± 12.7 | 9.7 ± 12.8 |
| PFA ALA (g) | 81.7 ± 2.0 | NA | 83.0 ± 1.6 | NA |
Values are means ± SEs unless otherwise indicated. AI, Adequate Intake; ALA, α-linolenic acid; DFE, dietary folate equivalents; EAR, Estimated Average Requirement; NA, not available; PFA, polyunsaturated fatty acid; RAE, retinol activity equivalents; WMENO, women of menopausal age.
Usual intake of nutrients from food or food + supplements per biomarker amount category in all women aged 15–65 y, NHANES 2011–2016[1]
| Biomarker amount category | |||
|---|---|---|---|
| 25(OH)D2 + 25(OH)D3 (nmol/L) (NHANES 2011–2014) | <50 | 50 to <75 | 75–250[ |
| Vitamin D (D-2 + D-3) (µg)[ | |||
| | 1609 | 1551 | 1223 |
| % taking supplement | 15.2 ± 1.4 | 36.4 ± 1.8 | 62.6 ± 1.8 |
| Intake from food only | |||
| Mean | 3.5 ± 0.1* | 3.8 ± 0.2 | 4.2 ± 0.1 |
| % <EAR | >99* | 98.4 ± 0.4 | 97.7 ± 0.5 |
| % >UL | <1 | <1 | <1 |
| Intake from food + supplements | |||
| Mean | 5.5 ± 0.3* | 10.6 ± 0.7* | 28.9 ± 2.2 |
| % <EAR | 89.2 ± 1.1* | 70.8 ± 1.9* | 43.1 ± 1.9 |
| % >UL | <1* | <1* | 5.6 ± 1.4 |
| Serum total folate (nmol/L) (NHANES 2011–2016) | <10[ | ≥10[ | — |
| Folate, DFE (µg) | |||
| | 48 | 6447 | — |
| % taking supplement | 1.7 ± 1.3 | 31.6 ± 1.0 | — |
| Intake from food only | |||
| Mean | 315.2 ± 25.9* | 463.8 ± 5.2 | — |
| % <EAR | 56.9 ± 8.8* | 18.4 ± 1.7 | — |
| Intake from food + supplements | |||
| Mean | 321.6 ± 24.9* | 663.5 ± 8.8 | — |
| % <EAR | 56.2 ± 8.5* | 14.2 ± 1.3 | — |
| Folic acid (µg) | |||
| | 48 | 6447 | — |
| % taking supplement | 1.7 ± 1.3 | 31.6 ± 1.0 | — |
| Intake from food only | |||
| Mean | 99.2 ± 12.6* | 157.7 ± 2.4 | — |
| % >UL | <1 | <1 | — |
| Intake from food + supplements | |||
| Mean | 103.0 ± 12.2* | 275.2 ± 4.5 | — |
| % >UL | <1* | 4.1 ± 0.3 | — |
| RBC folate (nmol/L) (NHANES 2011–2016) | <340[ | 340–906 | ≥906[ |
| Folate, DFE (µg) | |||
| | 39 | 2380 | 4128 |
| % taking supplement | 6.4 ± 3.8 | 15.6 ± 0.9 | 38.9 ± 1.1 |
| Intake from food only | |||
| Mean | 314.9 ± 32.0* | 408.3 ± 7.9* | 487.8 ± 5.7 |
| % <EAR | 57.8 ± 10.7* | 28.7 ± 2.5* | 13.7 ± 1.4 |
| Intake from food + supplements | |||
| Mean | 380.2 ± 55.5* | 482.3 ± 9.6* | 742.6 ± 10.9 |
| % <EAR | 54.6 ± 9.8* | 25.2 ± 2.1* | 9.3 ± 1.0 |
| Folic acid (µg) | |||
| | 39 | 2380 | 4128 |
| % taking supplement | 6.4 ± 3.8 | 15.6 ± 0.9 | 38.9 ± 1.1 |
| Intake from food only | |||
| Mean | 96.0 ± 13.3* | 137.6 ± 3.3* | 166.2 ± 2.9 |
| % >UL | <1 | <1 | <1 |
| Intake from food + supplements | |||
| Mean | 134.4 ± 34.1* | 181.1 ± 4.5 | 316.1 ± 5.7 |
| % >UL | 4.2 ± 3.4 | 0.7 ± 0.1* | 5.4 ± 0.5 |
| Vitamin B-12 (pmol/L) (NHANES 2011–2014) | <201[ | 201–301 | >301[ |
| Vitamin B-12 (µg) | |||
| | 290 | 789 | 2642 |
| % taking supplement | 16.9 ± 3.0 | 26.7 ± 2.8 | 42.2 ± 1.5 |
| Intake from food only | |||
| Mean | 3.6 ± 0.2* | 3.7 ± 0.1* | 4.3 ± 0.1 |
| % <EAR | 12.4 ± 3.0 | 10.9 ± 1.9* | 5.3 ± 1.0 |
| Intake from food + supplements | |||
| Mean | 7.8 ± 1.9* | 21.2 ± 3.1 | 110.7 ± 15.6 |
| % <EAR | 10.3 ± 2.7* | 8.4 ± 1.4* | 3.3 ± 0.7 |
| Ferritin (µg/L) | <15 | 15–150[ | >150 |
| Iron (mg) | |||
| | 305 | 1121 | 74 |
| % taking supplement | 16.5 ± 3.9 | 17.7 ± 2.3 | 23.3 ± 3.9 |
| Intake from food only | |||
| Mean | 12.4 ± 0.7 | 12.1 ± 0.2 | 11.5 ± 0.7 |
| % <EAR | 10.1 ± 4.2 | 11.9 ± 2.4 | 14.5 ± 5.6 |
| % >UL | <1 | <1 | <1 |
| Intake from food + supplements | |||
| Mean | 17.9 ± 1.7 | 15.6 ± 0.7 | 19.4 ± 3.4 |
| % <EAR | 9.1 ± 3.7 | 10.5 ± 2.0 | 12.3 ± 4.3 |
| % >UL | 5.2 ± 2.0 | 2.2 ± 0.6 | 6.5 ± 2.8 |
| Transferrin receptor (mg/L) (NHANES 2015–2016) | ≤4.4[ | >4.4 | — |
| Iron (mg) | |||
| | 1118 | 355 | — |
| % taking supplement | 18.1 ± 1.7 | 15.5 ± 3.2 | — |
| Intake from food only | |||
| Mean | 12.2 ± 0.2 | 11.9 ± 0.7 | — |
| % <EAR | 11.5 ± 2.3 | 13.1 ± 4.5 | — |
| % >UL | <1 | <1 | — |
| Intake from food + supplements | |||
| Mean | 15.8 ± 0.7 | 17.0 ± 0.9 | — |
| % <EAR | 10.1 ± 1.9 | 11.6 ± 4.0 | — |
| % >UL | 2.2 ± 0.6 | 4.3 ± 0.9 | — |
| EPA (µmol/L) (NHANES 2011–2012) | <38 | 38 to <64.7 | ≥64.7[ |
| PFA EPA (g) | |||
| | 376 | 306 | 298 |
| % taking supplement | 1.2 ± 0.6 | 3.3 ± 1.6 | 7.0 ± 1.6 |
| Intake from food only | |||
| Mean | 0.016 ± 0.002 | 0.015 ± 0.002 | 0.018 ± 0.002 |
| Intake from food + supplements | |||
| Mean ± SE | 0.017 ± 0.002 | 0.020 ± 0.002 | 0.031 ± 0.005 |
| DHA (µmol/L) (NHANES 2011–2012) | <117 | 117 to <172 | ≥172[ |
| PFA DHA (g) | |||
| | 309 | 338 | 330 |
| % taking supplement | 1.5 ± 1.0 | 2.2 ± 0.8 | 8.8 ± 2.4 |
| Intake from food only | |||
| Mean | 0.037 ± 0.005* | 0.050 ± 0.006 | 0.070 ± 0.006 |
| Intake from food + supplements | |||
| Mean | 0.038 ± 0.005* | 0.052 ± 0.006* | 0.080 ± 0.006 |
| ALA (µmol/L) (NHANES 2011–2012) | <65.6 | 65.6 to <91.0 | ≥91.0[ |
| PFA ALA (g) | |||
| | 361 | 297 | 319 |
| % taking supplement | NA | NA | NA |
| Intake from food only | |||
| Mean | 1.48 ± 0.05 | 1.59 ± 0.06 | 1.66 ± 0.06 |
| % <EAR | 76.7 ± 5.1 | 83.4 ± 4.0 | 85.9 ± 2.8 |
Values are means ± SEs unless otherwise indicated. *Significantly different [P < 0.01 (α = 0.01, 1-sided z test)] from highest biomarker category; ALA, α-linolenic acid; EAR, Estimated Average Requirement; NA, not available; PFA, polyunsaturated fatty acid; UL, upper tolerable limit; 25(OH)D, 25-hydroxyvitamin D.
Reference category for statistical comparisons.
For vitamin D, the woman in the “risk of excess” category (>250 nmol/L; n = 1) was removed from the analysis.
For serum folate, the women in the “risk of megaloblastic anemia” category (<7 nmol/L; n = 10) were combined with those in the “possible deficiency” category (7–9 nmol/L).
For RBC folate, the women in the “risk of megaloblastic anemia” category (<305 nmol/L; n = 25) were combined with those in the “possible deficiency” category (306–339 nmol/L).
For vitamin B-12, the women in the “deficient” category (<100 pmol/L; n = 18) were combined with those in the “moderately low” category (101–200 pmol/L).